Myelofibrosis News and Research

RSS
Study reveals HCT as effective treatment for NHL patients regardless of age

Study reveals HCT as effective treatment for NHL patients regardless of age

New genetic model identified for predicting outcomes in patients with primary myelofibrosis

New genetic model identified for predicting outcomes in patients with primary myelofibrosis

BUSM researchers show how MRI can effectively identify bone marrow cancer in experimental model

BUSM researchers show how MRI can effectively identify bone marrow cancer in experimental model

Study finds new therapeutic target to prevent progression of rare blood cancer

Study finds new therapeutic target to prevent progression of rare blood cancer

New NCCN Guidelines outline diagnosis, treatment strategies for myeloproliferative neoplasms

New NCCN Guidelines outline diagnosis, treatment strategies for myeloproliferative neoplasms

CTI BioPharma announces Q4 and FY 2015 earnings

CTI BioPharma announces Q4 and FY 2015 earnings

Penn study forms basis for new treatment approaches for Sezary syndrome

Penn study forms basis for new treatment approaches for Sezary syndrome

Imetelstat drug shows promise in treating patients with myelofibrosis

Imetelstat drug shows promise in treating patients with myelofibrosis

Hedgehog blockade promising in myeloid malignancies

Hedgehog blockade promising in myeloid malignancies

Researchers establish safety, dosing of new drug for treating blood cancers

Researchers establish safety, dosing of new drug for treating blood cancers

Targeted agent pacritinib significantly reduces burden of advanced myelofibrosis in patients

Targeted agent pacritinib significantly reduces burden of advanced myelofibrosis in patients

Positive results from pacritinib Phase 3 trial for treatment of myelofibrosis presented at ASCO 2015

Positive results from pacritinib Phase 3 trial for treatment of myelofibrosis presented at ASCO 2015

The Project Data Sphere® initiative achieves 1st year milestones

The Project Data Sphere® initiative achieves 1st year milestones

Data from pacritinib Phase 3 PERSIST-1 trial in patients with myelofibrosis to be highlighted at ASCO

Data from pacritinib Phase 3 PERSIST-1 trial in patients with myelofibrosis to be highlighted at ASCO

Results of pacritinib Phase 2 study in myelofibrosis patients published in journal 'Blood'

Results of pacritinib Phase 2 study in myelofibrosis patients published in journal 'Blood'

Pacritinib for myelofibrosis meets primary endpoint in Phase 3 PERSIST-1 trial

Pacritinib for myelofibrosis meets primary endpoint in Phase 3 PERSIST-1 trial

Researchers identify key events that prompt cancer cells to develop resistance to lethal therapies

Researchers identify key events that prompt cancer cells to develop resistance to lethal therapies

Novartis' JUMP study reinforces safety, efficacy of Jakavi (ruxolitinib) for myelofibrosis treatment

Novartis' JUMP study reinforces safety, efficacy of Jakavi (ruxolitinib) for myelofibrosis treatment

PRM-151 compound shows positive results for treating advanced myelofibrosis

PRM-151 compound shows positive results for treating advanced myelofibrosis

Jakafi receives expanded approval from FDA for use in treatment of polycythemia vera

Jakafi receives expanded approval from FDA for use in treatment of polycythemia vera